Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL3051658

CC(C)CCNCCOc1ccc(-c2ccc3[nH]cnc3c2)cc1.O=C(O)C(F)(F)F

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.42
RARB P10826 1/20 0.39
ADRB1 P08588 7/20 0.39
ADRB3 P13945 7/20 0.39
NAMPT P43490 1/20 0.38
P2RY14 Q15391 1/20 0.37
HPGD P15428 1/20 0.36
MAPK1 P28482 1/20 0.36
NOD2 Q9HC29 1/20 0.35
NOD1 Q9Y239 1/20 0.35
HDAC1 Q13547 2/20 0.34
HDAC2 Q92769 2/20 0.34
EPHX2 P34913 1/20 0.34
HDAC3 O15379 1/20 0.34
HDAC4 P56524 1/20 0.34
HDAC7 Q8WUI4 1/20 0.34
HDAC10 Q969S8 1/20 0.34
HDAC11 Q96DB2 1/20 0.34
HDAC8 Q9BY41 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL3047546 0.92 HTT (0.40) HTTNAMPTHPGDHDAC1HDAC2
Trifluoroacetic Acid SCHEMBL3047191 0.86 HDAC1 (0.45) HTTNAMPTHDAC1HDAC2HDAC3
SCHEMBL13136891 0.82 HTT (0.49) HTTNAMPTP2RY14
Trifluoroacetic Acid SCHEMBL3047291 0.81 HTR5A (0.41) ADRB1ADRB3P2RY14NOD2NOD1
Trifluoroacetic Acid SCHEMBL3046284 0.81 TAAR1 (0.41) NAMPTNOD2NOD1
SCHEMBL3051661 0.80 HTT (0.36) HTTRARBADRB1ADRB3NAMPT
Trifluoroacetic Acid SCHEMBL1875536 0.80 HTT (0.41) HTTNAMPT
Trifluoroacetic Acid SCHEMBL3045182 0.78 HDAC1 (0.43) HTTHDAC1
Trifluoroacetic Acid SCHEMBL3042666 0.77 ALDH1A1 (0.42) RARBP2RY14HPGDNOD2NOD1
SCHEMBL13136885 0.74 HTT (0.47) HTTNAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100222345-A1 NOVEL COMPOUNDS AS ANTAGONISTS OR INVERSE AGONISTS FOR OPIOID RECEPTORS SMITHKLINE BEECHAM CORPORATION 2010-09-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100222345-A1 NOVEL COMPOUNDS AS ANTAGONISTS OR INVERSE AGONISTS FOR OPIOID RECEPTORS OPRL1, OPRM1, OPRK1 HTT 1472/4885RARB 441/4885ADRB1 9/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.